229 related articles for article (PubMed ID: 25142405)
21. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders.
Carpentier PJ; de Jong CA; Dijkstra BA; Verbrugge CA; Krabbe PF
Addiction; 2005 Dec; 100(12):1868-74. PubMed ID: 16367988
[TBL] [Abstract][Full Text] [Related]
22. Attention deficit hyperactivity disorder and substance misuse: an evaluation of causal hypotheses and treatment considerations.
Young S; Sedgwick O
Expert Rev Neurother; 2015; 15(9):1005-14. PubMed ID: 26289485
[TBL] [Abstract][Full Text] [Related]
23. Investigating the efficacy of integrated cognitive behavioral therapy for adult treatment seeking substance use disorder patients with comorbid ADHD: study protocol of a randomized controlled trial.
van Emmerik-van Oortmerssen K; Vedel E; Koeter MW; de Bruijn K; Dekker JJ; van den Brink W; Schoevers RA
BMC Psychiatry; 2013 May; 13():132. PubMed ID: 23663651
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological Treatment of ADHD in Addicted Patients: What Does the Literature Tell Us?
Carpentier PJ; Levin FR
Harv Rev Psychiatry; 2017; 25(2):50-64. PubMed ID: 28272130
[TBL] [Abstract][Full Text] [Related]
25. Clinical practice guideline on pharmacological and psychological management of adult patients with attention deficit and hyperactivity disorder and comorbid substance use.
Cunill R; Castells X; González-Pinto A; Arrojo M; Bernardo M; Sáiz PA; Flórez G; Torrens M; Tirado-Muñoz J; Fonseca F; Arranz B; Garriga M; Goikolea JM; Zorrilla I; Becoña E; López A; San L
Adicciones; 2022 Apr; 34(2):168-178. PubMed ID: 34171106
[TBL] [Abstract][Full Text] [Related]
26. Pharmacotherapy for Attention-Deficit/Hyperactivity Disorder and Retention in Outpatient Substance Use Disorder Treatment: A Retrospective Cohort Study.
Kast KA; Rao V; Wilens TE
J Clin Psychiatry; 2021 Feb; 82(2):. PubMed ID: 33988929
[TBL] [Abstract][Full Text] [Related]
27. Treatments for Adolescents With Comorbid ADHD and Substance Use Disorder: A Systematic Review.
Zaso MJ; Park A; Antshel KM
J Atten Disord; 2020 Jul; 24(9):1215-1226. PubMed ID: 25655767
[No Abstract] [Full Text] [Related]
28. Attention-deficit/hyperactivity disorder and substance abuse.
Harstad E; Levy S;
Pediatrics; 2014 Jul; 134(1):e293-301. PubMed ID: 24982106
[TBL] [Abstract][Full Text] [Related]
29. Long-term outcomes of pharmacologically treated versus non-treated adults with ADHD and substance use disorder: a naturalistic study.
Bihlar Muld B; Jokinen J; Bölte S; Hirvikoski T
J Subst Abuse Treat; 2015 Apr; 51():82-90. PubMed ID: 25491733
[TBL] [Abstract][Full Text] [Related]
30. Substance Use Disorder in Adult-Attention Deficit Hyperactive Disorder Patients: Patterns of Use and Related Clinical Features.
Spera V; Pallucchini A; Maiello M; Carli M; Maremmani AGI; Perugi G; Maremmani I
Int J Environ Res Public Health; 2020 May; 17(10):. PubMed ID: 32429586
[TBL] [Abstract][Full Text] [Related]
31. Placebo Response and Its Predictors in Attention Deficit Hyperactivity Disorder: A Meta-Analysis and Comparison of Meta-Regression and MetaForest.
Castells X; Saez M; Barcheni M; Cunill R; Serrano D; López B; van Lissa CJ
Int J Neuropsychopharmacol; 2022 Jan; 25(1):26-35. PubMed ID: 34355753
[TBL] [Abstract][Full Text] [Related]
32. ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study.
Dalsgaard S; Mortensen PB; Frydenberg M; Thomsen PH
Addict Behav; 2014 Jan; 39(1):325-8. PubMed ID: 24090624
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis.
van Emmerik-van Oortmerssen K; van de Glind G; van den Brink W; Smit F; Crunelle CL; Swets M; Schoevers RA
Drug Alcohol Depend; 2012 Apr; 122(1-2):11-9. PubMed ID: 22209385
[TBL] [Abstract][Full Text] [Related]
34. Attention-deficit/hyperactivity disorder subtypes in adolescents with comorbid substance-use disorder.
Tamm L; Adinoff B; Nakonezny PA; Winhusen T; Riggs P
Am J Drug Alcohol Abuse; 2012 Jan; 38(1):93-100. PubMed ID: 21834613
[TBL] [Abstract][Full Text] [Related]
35. The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults.
Najib J
Clin Ther; 2009 Jan; 31(1):142-76. PubMed ID: 19243715
[TBL] [Abstract][Full Text] [Related]
36. Relationship Between Treatment Duration and Efficacy of Pharmacological Treatment for ADHD: A Meta-Analysis and Meta-Regression of 87 Randomized Controlled Clinical Trials.
Castells X; Ramon M; Cunill R; Olivé C; Serrano D
J Atten Disord; 2021 Aug; 25(10):1352-1361. PubMed ID: 32075485
[No Abstract] [Full Text] [Related]
37. Adult attention-deficit/hyperactivity disorder and its association with substance use and substance use disorders in young men.
Estévez N; Dey M; Eich-Höchli D; Foster S; Gmel G; Mohler-Kuo M
Epidemiol Psychiatr Sci; 2016 Jun; 25(3):255-66. PubMed ID: 25989844
[TBL] [Abstract][Full Text] [Related]
38. Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.
Upadhyaya HP
J Clin Psychiatry; 2007; 68 Suppl 11():23-30. PubMed ID: 18307378
[TBL] [Abstract][Full Text] [Related]
39. The clinical dilemma of using medications in substance-abusing adolescents and adults with attention-deficit/hyperactivity disorder: what does the literature tell us?
Wilens TE; Monuteaux MC; Snyder LE; Moore H; Whitley J; Gignac M
J Child Adolesc Psychopharmacol; 2005 Oct; 15(5):787-98. PubMed ID: 16262595
[TBL] [Abstract][Full Text] [Related]
40. Methylphenidate treatment of adult male prison inmates with attention-deficit hyperactivity disorder: randomised double-blind placebo-controlled trial with open-label extension.
Ginsberg Y; Lindefors N
Br J Psychiatry; 2012 Jan; 200(1):68-73. PubMed ID: 22075648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
